Chemotherapy-Induced Tumor Cell Death at the Crossroads Between Immunogenicity and Immunotolerance: Focus on Acute Myeloid Leukemia

Overview of attention for article published in Frontiers in oncology, October 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 28 Dimensions

Readers on

mendeley: 37 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 28 publications that cite this research output.

28

The most recent citing publications are shown below. View all 28 publications that cite this research output on Dimensions.

Emerging role of immunogenic cell death in cancer immunotherapy: Advancing next-generation CAR-T cell immunotherapy by combination

Article in Cancer Letters (June 2024)

Ex vivo characterization of acute myeloid leukemia patients undergoing hypomethylating agents and venetoclax regimen reveals a venetoclax-specific effect on non-suppressive regulatory T cells and bona fide PD-1+TIM3+ exhausted CD8+ T cells

Article in Frontiers in Immunology (May 2024)

Deregulation of New Cell Death Mechanisms in Leukemia

Article in Cancers (April 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.